Bipolar spectrum disorders are characterized by disturbances in mood regulation involving episodes of elevated, expansive, or irritable mood, often accompanied by changes in energy, activity, sleep, cognition, and behavior. These conditions differ from unipolar depression by their episodic or cyclical course and the presence of manic or hypomanic symptoms.
Manic and hypomanic states involve more than elevated mood. They may include increased goal-directed activity, reduced need for sleep, racing thoughts, impulsivity, grandiosity, risk-taking, and changes in social or occupational functioning. The bipolar spectrum is often conceptualized dimensionally, ranging from subclinical hypomanic traits to clinically significant manic episodes.
Screening instruments are used to identify individuals who may require further evaluation for bipolar disorder, especially when depressive symptoms are present. They are especially important because bipolar disorder may initially present as depression and can be misidentified as unipolar depressive disorder.
The Mood Disorder Questionnaire (MDQ) is one of the most widely used screening tools, assessing lifetime history of manic or hypomanic symptoms and their impact on functioning.
The Bipolar Spectrum Diagnostic Scale (BSDS) assesses a broader range of bipolar spectrum features, including milder or less typical presentations.
The Rapid Mood Screener (RMS) is a brief screening tool developed to help distinguish bipolar I disorder from major depressive disorder in people presenting with depressive symptoms.
The General Behavior Inventory (GBI) assesses depressive and hypomanic or biphasic symptoms over time, providing a dimensional view of mood variability and bipolar-spectrum features.
These measures assess current, recent, or lifetime manic and hypomanic symptoms. They may focus on lifetime hypomanic patterns, current self-reported manic symptoms, clinician-rated severity, or manic symptoms in children and adolescents.
The Hypomania Checklist (HCL-32) assesses a broad range of hypomanic symptoms, including elevated mood, increased activity, reduced need for sleep, social disinhibition, and increased confidence.
The Altman Self-Rating Mania Scale (ASRM) provides a brief measure of current manic symptom severity, focusing on mood, activity, sleep, speech, and self-confidence.
The Young Mania Rating Scale (YMRS) is a clinician-rated measure of manic symptom severity, widely used in clinical research and treatment monitoring.
The Bech-Rafaelsen Mania Rating Scale (BRMS) assesses the severity of manic symptoms, including elevated mood, increased activity, reduced sleep, pressured speech, and disruptive behavior.
The Child Mania Rating Scale (CMRS-P) assesses manic symptoms in children and adolescents using parent report.
These instruments assess current internal mood states and mood fluctuations rather than only lifetime symptoms. They are useful for tracking changes over time and distinguishing combinations of activation, depression, subjective conflict, and perceived well-being.
The Internal State Scale (ISS) measures mood-related states associated with bipolar disorder, including Activation, Well-Being, Perceived Conflict, and Depression.
These instruments assess hypomanic traits as a relatively stable personality-like pattern rather than as a current mood episode. They describe trait-like vulnerability to elevated energy, social confidence, risk-taking, excitement seeking, and cognitive or behavioral activation.
The Hypomanic Personality Scale (HPS) assesses traits such as elevated energy, confidence, sociability, optimism, increased activity, and emotional intensity.
⇒ Depression. Bipolar-spectrum disorders may present with depressive episodes, but require assessment of manic or hypomanic symptoms to distinguish them from unipolar depression.
⇒ ADHD may overlap with bipolar-spectrum symptoms through impulsivity, distractibility, restlessness, and increased activity, but bipolar symptoms are more episodic and tied to mood, sleep, and energy changes.
Assessment of bipolar spectrum conditions usually combines screening, current symptom evaluation, lifetime history of hypomanic or manic symptoms, mood-state monitoring, and functional assessment.
Bipolar screening tools are not diagnostic on their own. A positive screen indicates the need for more comprehensive evaluation, especially when depressive symptoms, episodic mood elevation, reduced need for sleep, impulsivity, or risk-taking are present.
Interpretation should focus on episodicity, change from baseline functioning, duration of symptoms, sleep changes, family history, substance use, comorbid conditions, and functional impact. Clinical evaluation is necessary to determine whether symptoms represent bipolar disorder, another condition, or non-clinical variation in mood and energy.